Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BYLIUM LIQ 176 MG / 10 ML

PEPTONE : 176 MG / 10 ML PANCREATIN : 176 MG / 10 ML MAGNESIUM SULFATE : 1.521 G / 10 ML BOLDO : 176 MG / 10 ML CASCARA SAGRADA : .35 ML / 10 ML · DIN 00378607 · SUPERCO ENR.

Health Canada status: CANCELLED POST MARKET

What is BYLIUM LIQ?

BYLIUM LIQ 176 MG / 10 ML contains PEPTONE : 176 MG / 10 ML PANCREATIN : 176 MG / 10 ML MAGNESIUM SULFATE : 1.521 G / 10 ML BOLDO : 176 MG / 10 ML CASCARA SAGRADA : .35 ML / 10 ML. It is listed in the Health Canada Drug Product Database under DIN 00378607, held by SUPERCO ENR., supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 07-Jun-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN00378607
Brand nameBYLIUM LIQ
Generic / active ingredientPEPTONE : 176 MG / 10 ML PANCREATIN : 176 MG / 10 ML MAGNESIUM SULFATE : 1.521 G / 10 ML BOLDO : 176 MG / 10 ML CASCARA SAGRADA : .35 ML / 10 ML
ManufacturerSUPERCO ENR.
Strength176 MG / 10 ML
Dosage formLIQUID
Route of administrationORAL
ScheduleNON-PRESCRIPTION DRUGS
ATC codeA06AB57 CASCARA, COMBINATIONS
AHFS class56:12.00
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date07-Jun-2000
Original market date1977-12-31 00:00:00

What can be used instead?

Other Canadian products sharing ATC code A06AB57 CASCARA, COMBINATIONS. 0 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ACIDOBYL & CASCARA20 MGTABLETDESBERGERS LTÉE, DIVISION OF TECHNILAB INC.CANCELLED POST MARKETDIN 00086762
ALSILAX528 MG / 30 MLLIQUIDALSI CIE LTEECANCELLED POST MARKETDIN 00468355
CHOLETOL17.6 MGLIQUIDLES LABORATOIRES VACHON INC.CANCELLED POST MARKETDIN 00482382
DEPURATEX100.9 MG / 100 MLLIQUIDLABORATOIRE LALCO INC.CANCELLED POST MARKETDIN 00491594
DEPURATON100.9 MG / 100 MLLIQUIDBIODO ENRGCANCELLED POST MARKETDIN 00491632
ELIXIR 10114.4 MGLIQUIDFREGA INC.CANCELLED POST MARKETDIN 00477168
FORMULA 10015 MG / 28 MLLIQUIDVITALABCANCELLED POST MARKETDIN 00840866
HERBASAN209 MG / 30 MLLIQUIDSANTÉ NATURELLE (AG) LTÉECANCELLED POST MARKETDIN 00559849
HERBATOL LAX LIQ15 MG / 15 MLLIQUIDCARDINAUX ENRG LES PRODUITS NATURELSCANCELLED POST MARKETDIN 00731889
HERBOREX FORT LAX LIQ325 MG / 30 MLLIQUIDROLMEX INTERNATIONAL INC.CANCELLED POST MARKETDIN 00402273

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for BYLIUM LIQ

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 00378607. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.